UGT1A7 and glomerulonephritis: Since mycophenolic acid is a substrate for UGT1A7 [41] and SLE and SVV patients have reduced UGT1A7 transcript expression relative to healthy controls, the glomerulonephritis patients would be predicted to have a lower metabolism of mycophenolic acid through UGT1A7 within the leukocytes.